COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,036 Articles (22,627 medRxiv, 8,409 bioRxiv)

Most recent first Previous |  Page 2229: Articles 22281-22290  | Next

Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo
Schaefer, A., Muecksch, F., Lorenzi, J. C. C., Leist, S. R., Cipolla, M., Bournazos, S., Schmidt, F., Gazumyan, A., Baric, R. S., Robbiani, D. F., Hatziioannou, T., Ravetch, J. V., Bieniasz, P. D., Nussenzweig, M. C., Sheahan, T. P.
10.1101/2020.09.15.298067 — Posted: 2020-09-15
Ceftazidime Is a Potential Drug to Inhibit SARS-CoV-2 Infection In Vitro by Blocking Spike Protein-ACE2 Interaction
Lin, C., Li, Y., Yuan, M., Huang, M., Liu, C., Du, H., Pan, X., Wen, Y., Xu, X., Xu, C., Chen, J.
10.1101/2020.09.14.295956 — Posted: 2020-09-15
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy
Basar, R., Uprety, N., Ensley, E., Daher, M., Klein, K., Martinez, F., Aung, F., Shanley, M., Hu, B., Gokdemir, E., Mendt, M., Reyes Silva, F., Acharya, S., Laskowski, T., Muniz-Feliciano, L., Banerjee, P., Li, Y., Li, S., Melo Garcia, L., Lin, P., Shaim, H., Yates, S. G., Marin, D., Kaur, I., Rao, S., Mak, D., Lin, A., Miao, Q., Dou, J., Chen, K., Champlin, R., Shpall, E. J., Rezvani, K.
10.1101/2020.09.15.298547 — Posted: 2020-09-15
Predictors of characteristics associated with negative SARS-CoV-2 PCR test despite proven disease and association with treatment and outcomes.The COVID-19 RT-PCR Study.
Lascarrou, J. B., Colin, G., Le Thuaut, A., Serck, N., Ohana, M., Sauneuf, B., Geri, G., Mesland, J. B., Ribeyre, G., Hussenet, C., Boureau, A. S., Gille, T.
10.1101/2020.09.14.20194001 — Posted: 2020-09-15
SARS-CoV-2 N-antigenemia: A new alternative to nucleic acid amplification techniques
Le Hingrat, Q., Visseaux, B., Laouenan, C., Tubiana, S., Bouadma, L., Yazdanpanah, Y., Duval, X., Ichou, H., Damond, F., Bertine, M., Benmalek, N., French COVID cohort management committee, , CoV-CONTACT study group, , Choquet, C., Timsit, J.-F., Ghosn, J., Charpentier, C., Descamps, D., Houhou-Fidouh, N.
10.1101/2020.09.14.20191759 — Posted: 2020-09-15
SARS-CoV-2 in wastewater settled solids is associated with COVID-19 cases in a large urban sewershed
Graham, K., Loeb, S., Wolfe, M., Catoe, D., Sinnott-Armstrong, N., Kim, S., Yamahara, K., Sassoubre, L., Mendoza, L., Roldan-Hernandez, L., Li, L., Wigginton, K., Boehm, A.
10.1101/2020.09.14.20194472 — Posted: 2020-09-15
Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia: 2 an analysis of 12,066 hospitalized patients from the Spanish registry SEMI-3 COVID-19.
Rubio-Rivas, M., Corbella, X., Mora-Lujan, J. M., Loureiro Amigo, J., Lopez Sampalo, A., Yera Bergua, C., Esteve Atienzar, P. J., Diez Garcia, L. F., Gonzalez Ferrer, R., Plaza Canteli, S., Perez Pineiro, A., Cortes Rodriguez, B., Jorquer Vidal, L., Perez Catalan, I., Leon Tellez, M., Martin Oterino, J. A., Martin Gonzalez, M. C., Serrano Carrillo de Albornoz, J. L., Garcia Sardon, E., Alcala Pedrajas, J. N., Martin Urda Diez Canseco, A., Esteban Giner, M. J., Telleria Gomez, P., Gomez Huelgas, R., Ramos Rincon, J. M.
10.1101/2020.09.14.20193995 — Posted: 2020-09-15
Characterization and Phase 1 Trial of a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
Willingham, S. B., Criner, G., Hill, C., Hu, S., Rudnick, J. A., Daine-Matsuoka, B., Hsieh, J., Mashhedi, H., Hotson, A. N., Brody, J., Marron, T., Piccione, E., Buggy, J. J., Mahabhashyam, S., Jones, W. B., Mobasher, M., Miller, R. A.
10.1101/2020.09.10.20191486 — Posted: 2020-09-15
Mathematical Modelling of the Spread of the Coronavirus under Social Restrictions
Al-arydah, M., Dib, K., Berhe, H. W., Madhu, K.
10.1101/2020.09.14.20194068 — Posted: 2020-09-15
Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: a meta-analysis
Simadibrata, D. M., Calvin, J., Wijaya, A. D., Ibrahim, N. A. A.
10.1101/2020.09.14.20191098 — Posted: 2020-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).